Taking the latter into account, and as previously described for other tumour suppressor genes [39,40], PTEN mRNA molecular screening investigations are necessary to obtain more precise molecular diagnoses, with a view to better characterizing PHTS patients and probably to explain the PHTS cases that remain without identified molecular alterations. This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.